Uğraklı, M. Et Al. 2023. The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.. Journal of cancer research and clinical oncology .

Uğraklı, M., Koçak, M. Z., Dinç, G., Genç, T. B., Çağlayan, M., Uğraklı, S., ... Hendem, E.(2023). The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.. Journal of cancer research and clinical oncology .

Uğraklı, Muzaffer Et Al. "The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.," Journal of cancer research and clinical oncology , 2023

Uğraklı, Muzaffer Et Al. "The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.." Journal of cancer research and clinical oncology , 2023

Uğraklı, M. Et Al. (2023) . "The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.." Journal of cancer research and clinical oncology .

@article{article, author={Muzaffer Uğraklı Et Al. }, title={The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.}, journal={Journal of cancer research and clinical oncology}, year=2023}